Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Absorica LD (isotretinoin)
- etranacogene dezaparvovec
Interactions between your drugs
ISOtretinoin etranacogene dezaparvovec
Applies to: Absorica LD (isotretinoin), etranacogene dezaparvovec
Etranacogene dezaparvovec can cause liver problems, which may make the medication less effective in treating your condition. Using other medications that can also affect the liver such as ISOtretinoin after receiving etranacogene dezaparvovec may increase that risk. Symptoms of liver problems include fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark urine, pale stools, and/or yellowing of the skin or eyes. Blood tests to monitor liver function should be performed before and after treatment with etranacogene dezaparvovec. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
ISOtretinoin food
Applies to: Absorica LD (isotretinoin)
Ask your doctor before using ISOtretinoin together with ethanol (alcohol). Do not drink alcohol while you are taking ISOtretinoin. You may have unpleasant side effects such as fast heartbeats, warmth or redness under your skin, tingly feeling, nausea, and vomiting. Check your food and medicine labels to be sure these products do not contain alcohol. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Clindamycin topical
Clindamycin topical is used for acne, bacterial vaginosis, perioral dermatitis
Vibramycin
Vibramycin is used for acne, actinomycosis, amebiasis, anthrax, anthrax prophylaxis, bacterial ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tazorac
Tazorac cream and gel is used to treat acne and plaque psoriasis. Includes Tazorac side effects ...
Soolantra
Soolantra (ivermectin) is used to treat rosacea. Includes Soolantra side effects, interactions and ...
Minocycline topical
Minocycline topical is used for acne, periodontitis, rosacea
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.